Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Magdolna Seszták"'
Autor:
Ilona Ujfalussy, Pál Géher, Márta Péntek, Gábor Horváth, László Hodinka, Sándor Szántó, László Gulácsi, Valentin Brodszky, Éva Koó, Magdolna Seszták, Peter V. Balint, Anna Polgár
Publikováno v:
Rheumatology International
Rheumatology International, Springer Verlag, 2009, 30 (2), pp.199-205. ⟨10.1007/s00296-009-0936-1⟩
Rheumatology International, Springer Verlag, 2009, 30 (2), pp.199-205. ⟨10.1007/s00296-009-0936-1⟩
International audience; The objectives of this study were to assess the costs of psoriatic arthritis (PsA) in Hungary and to identify key cost drivers among demographic and clinical variables and to compare cost-of-illness of PsA and rheumatoid arthr
Publikováno v:
Zeitschrift f�r Rheumatologie. 62:155-160
102 rheumatoid arthritis (RA) and 104 psoriatic arthritis (PsA) patients' records were analysed according to a standardised protocol. Using Cox regression, life-table analysis and log rank test, the effectiveness and toxicity of, and duration of dise
Autor:
Magdolna Seszták, Krisztina Baraczka, Kristóf Nékám, Lajos Jakab, Mariann Szongoth, Teréz Pozsonyi
Publikováno v:
Neuroimmunomodulation. 9:49-54
Objectives: The aim of the present study was to investigate the role of soluble adhesion molecules in the pathogenesis of multiple sclerosis (MS) and systemic lupus erythematosus (SLE) with demyelinating syndrome. Methods: Paired cerebrospinal fluid
Autor:
Ottó Hajdu, Peter V. Balint, Ilona Ujfalussy, Gábor Horváth, É. Koó, László Hodinka, Magdolna Seszták, Sándor Szántó, Valentin Brodszky, Anna Polgár, László Gulácsi, Pál Géher, Márta Péntek
Publikováno v:
Scandinavian journal of rheumatology. 39(4)
To compare the Psoriatic Arthritis Quality of Life (PsAQoL) instrument, the Health Assessment Questionnaire (HAQ) as a measure of functional status, and the generic health status (utility) measure the EuroQoL (EQ-5D) in terms of ability to assess dis
Publikováno v:
Orvosi hetilap. 147(50)
HLA antigens were studied in 100 Hungarian patients suffered from psoriatic arthritis. Genetic markers for the development of different clinical pattern of the disease and skin disorder were identified.Determination of class I and class II antigens w